These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 22656882)
41. [Development of novel therapies using human iPS cell-derived retinal pigment epithelia]. Arakawa D; Ito A; Osakada F Nihon Yakurigaku Zasshi; 2016; 148(4):217. PubMed ID: 27725570 [No Abstract] [Full Text] [Related]
42. Polarized human embryonic stem cell-derived retinal pigment epithelial cell monolayers have higher resistance to oxidative stress-induced cell death than nonpolarized cultures. Hsiung J; Zhu D; Hinton DR Stem Cells Transl Med; 2015 Jan; 4(1):10-20. PubMed ID: 25411476 [TBL] [Abstract][Full Text] [Related]
43. [Novel approach for management of age-related macular degeneration--antiangiogenic therapy and retinal regenerative therapy]. Tamaki Y Nippon Ganka Gakkai Zasshi; 2007 Mar; 111(3):232-68; discussion 269. PubMed ID: 17402564 [TBL] [Abstract][Full Text] [Related]
44. Generation of retinal cells from pluripotent stem cells. Jin ZB; Takahashi M Prog Brain Res; 2012; 201():171-81. PubMed ID: 23186714 [TBL] [Abstract][Full Text] [Related]
45. Perspectives on human clinical trials of therapies using iPS cells in Japan: reaching the forefront of stem-cell therapies. Song P; Inagaki Y; Sugawara Y; Kokudo N Biosci Trends; 2013 Jun; 7(3):157-8. PubMed ID: 23836040 [TBL] [Abstract][Full Text] [Related]
46. Generation of retinal pigment epithelial cells from human embryonic stem cell-derived spherical neural masses. Cho MS; Kim SJ; Ku SY; Park JH; Lee H; Yoo DH; Park UC; Song SA; Choi YM; Yu HG Stem Cell Res; 2012 Sep; 9(2):101-9. PubMed ID: 22683799 [TBL] [Abstract][Full Text] [Related]
47. Microdevice-based cell therapy for age-related macular degeneration. Lu B; Tai YC; Humayun MS Dev Ophthalmol; 2014; 53():155-66. PubMed ID: 24732769 [TBL] [Abstract][Full Text] [Related]
48. Reduction in the drusenoid retinal pigment epithelium detachment area in the dry form of age-related macular degeneration 2.5 years after rheohemapheresis. Rencová E; Bláha M; Studnička J; Bláha V; Brožík J; Pazderová M; Rozsíval P; Langrová H Acta Ophthalmol; 2013 Aug; 91(5):e406-8. PubMed ID: 22971248 [No Abstract] [Full Text] [Related]
49. Transplantation of rat embryonic stem cell-derived retinal progenitor cells preserves the retinal structure and function in rat retinal degeneration. Qu Z; Guan Y; Cui L; Song J; Gu J; Zhao H; Xu L; Lu L; Jin Y; Xu GT Stem Cell Res Ther; 2015 Nov; 6():219. PubMed ID: 26553210 [TBL] [Abstract][Full Text] [Related]
50. Possible clinical usefulness of embryonic stem cells. Aznar J; Gómez I Rev Clin Esp; 2012 Sep; 212(8):403-6. PubMed ID: 22765959 [TBL] [Abstract][Full Text] [Related]
51. Subretinal Transplantation of Embryonic Stem Cell-Derived Retinal Pigment Epithelium for the Treatment of Macular Degeneration: An Assessment at 4 Years. Schwartz SD; Tan G; Hosseini H; Nagiel A Invest Ophthalmol Vis Sci; 2016 Apr; 57(5):ORSFc1-9. PubMed ID: 27116660 [TBL] [Abstract][Full Text] [Related]
52. Transplantation of retinal pigment epithelial, photoreceptor and other cells as treatment for retinal degeneration. Litchfield TM; Whiteley SJ; Lund RD Exp Eye Res; 1997 May; 64(5):655-66. PubMed ID: 9245894 [No Abstract] [Full Text] [Related]
53. Differentiation of human pluripotent stem cells to retinal pigmented epithelium in defined conditions using purified extracellular matrix proteins. Rowland TJ; Blaschke AJ; Buchholz DE; Hikita ST; Johnson LV; Clegg DO J Tissue Eng Regen Med; 2013 Aug; 7(8):642-53. PubMed ID: 22514096 [TBL] [Abstract][Full Text] [Related]